Top Markets
Coin of the day
MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

MyMD Pharmaceuticals, Inc.

MYMD
株式のランク #35400
MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical... MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical development stage, focused on devising diverse therapeutic strategies that target the underlying origins of various illnesses. One of its key initiatives is the development of MYMD-1, a drug platform centered on a small molecule presently undergoing clinical trials. This molecule works by regulating the immune system to suppress TNF-alpha, a major contributor to chronic inflammation, along with other pro-inflammatory cell-signaling proteins. MYMD-1 is being explored for its potential to delay aging, extend lifespan, manage autoimmune conditions, and treat depression linked to COVID-19. Furthermore, the company is advancing Supera-CBD, a synthetic version of cannabidiol, which aims to address chronic pain, addiction, and epilepsy. MyMD Pharmaceuticals was established in 2014 and its corporate headquarters are situated in Baltimore, Maryland.
株価
$1.85
最終同期: 2024-08-19
時価総額
$3.96M
変化(1日)
2.78%
変化(1年)
0.00%
US
取引 MyMD Pharmaceuticals, Inc. (MYMD)

カテゴリー

MyMD Pharmaceuticals, Inc.(MYMD)の配当利回りの履歴
MyMD Pharmaceuticals, Inc.(銘柄コード: MYMD)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
MyMD Pharmaceuticals, Inc.(MYMD)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)